Citigroup’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
176,556
+35,686
| +25% | +$401K | ﹤0.01% | 2046 |
|
|
2025
Q1 | $644K | Buy |
140,870
+22,436
| +19% | +$103K | ﹤0.01% | 2807 |
|
|
2024
Q4 | $668K | Buy |
118,434
+61,983
| +110% | +$350K | ﹤0.01% | 2837 |
|
|
2024
Q3 | $273K | Buy |
56,451
+14,288
| +34% | +$69.2K | ﹤0.01% | 3376 |
|
|
2024
Q2 | $206K | Sell |
42,163
-333,896
| -89% | -$1.63M | ﹤0.01% | 3142 |
|
|
2024
Q1 | $4.99M | Buy |
376,059
+232,344
| +162% | +$3.09M | ﹤0.01% | 1244 |
|
|
2023
Q4 | $2M | Buy |
143,715
+23,046
| +19% | +$321K | ﹤0.01% | 1647 |
|
|
2023
Q3 | $1.6M | Buy |
120,669
+31,126
| +35% | +$413K | ﹤0.01% | 1606 |
|
|
2023
Q2 | $1.68M | Sell |
89,543
-404,476
| -82% | -$7.58M | ﹤0.01% | 1828 |
|
|
2023
Q1 | $7.12M | Buy |
494,019
+328,340
| +198% | +$4.73M | 0.01% | 967 |
|
|
2022
Q4 | $3.21M | Sell |
165,679
-2,041
| -1% | -$39.5K | ﹤0.01% | 1263 |
|
|
2022
Q3 | $5.76M | Buy |
167,720
+159,472
| +1,933% | +$5.48M | ﹤0.01% | 1051 |
|
|
2022
Q2 | $126K | Sell |
8,248
-30,424
| -79% | -$465K | ﹤0.01% | 3429 |
|
|
2022
Q1 | $882K | Sell |
38,672
-82,485
| -68% | -$1.88M | ﹤0.01% | 2457 |
|
|
2021
Q4 | $4.47M | Buy |
121,157
+119,343
| +6,579% | +$4.4M | ﹤0.01% | 1358 |
|
|
2021
Q3 | $85K | Buy |
+1,814
| New | +$85K | ﹤0.01% | 3733 |
|